Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X026668 | — |
No additional AE; HCP called and reported inadvertent administration of GARDASIL 9 to a patient after a temperature excursion that occurred on 02DEC2024. Vaccine was administered after the excursion on 24DEC2024.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Patient's concurrent conditions, pertinent medical history and concomitant therapies were not provided. On 24-DEC-2024, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot #X026668, expiration date: 10-APR-2026, administered for prophylaxis (strength, route of administration, and anatomical location were not provided) that underwent a temperature excursion that occurred on 02-DEC-2024. The temperature excursion was 46.7 degrees Fahrenheit for the time frame of 192 hours. There was no previous temperature excursion. No adverse event.